BackOnconova Therapeutics- Warrants (01/08/2021) Overview
Onconova Therapeutics Inc - Warrants (01/08/2021)

Onconova Therapeutics- Warrants (01/08/2021) Return on Equity

Onconova Therapeutics- Warrants (01/08/2021) (ONTXW) has a ROE of -172367.12%, below the Healthcare sector average of 20.86%.

Get informed when a big investor buys or sells

+ Follow

ROE

-172367.12%

Return on Equity

-172367.12%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Onconova Therapeutics- Warrants (01/08/2021) (ONTXW) FAQ

The latest ROE for ONTXW is -172367.12%. That is below the Healthcare sector average of 20.86%. Investors often review this figure alongside Onconova Therapeutics- Warrants (01/08/2021)'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, ONTXW currently prints -172367.12% for ROE, while the sector average sits near 20.86%. That is roughly 826531.4% below the sector mean. Large gaps often invite a closer look at Onconova Therapeutics- Warrants (01/08/2021)'s growth, margins, and balance sheet.

Return on Equity shows how effectively Onconova Therapeutics- Warrants (01/08/2021) converts resources into returns. At -172367.12%, ONTXW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ONTXW's ROE (-172367.12%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Onconova Therapeutics- Warrants (01/08/2021)'s ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.